Insider · CIK 0002055843
Ajay Kumar Dhadha
Files at RAPH (Raphael Pharmaceutical Inc.). First filing -, latest -.
In brief
Ajay Kumar Dhadha files SEC Form 4 as director at RAPH (Raphael Pharmaceutical Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ajay Kumar Dhadha has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | RAPH Raphael Pharmaceutical Inc. | AGrant or award Common Stock | +350,000 | $0.00 | $0 | 351,667 | Mar 6, 2025 |
| Mar 5, 2025 | RAPH Raphael Pharmaceutical Inc. | AGrant or award Warrant to purchase Common Stockderivative | +250,000 | $0.00 | $0 | 250,000 | Mar 6, 2025 |
Questions about Ajay Kumar Dhadha
Answered from the filings on this page, as of the latest one.
Is Ajay Kumar Dhadha buying or selling?
Ajay Kumar Dhadha has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ajay Kumar Dhadha's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ajay Kumar Dhadha has 0.
Where does Ajay Kumar Dhadha file Form 4?
Ajay Kumar Dhadha has filed Form 4 at RAPH (Raphael Pharmaceutical Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.